News China29 May 2020

Listed company calls off planned merger with insurer

29 May 2020

Shenzhen listed Hubei Biocause Pharmaceutical has cancelled plans to merge with Guohua Life. Biocause currently hold a 51% stake in Guohua Life. The fundraising exercise to finance the acquisition of the remaining 41% stake was also aborted.

eWeekly China Newsletter is available to eChina subscribers only.

Please login to read the full news

Please Click here to subscribe eChina.

Note that your comment may be edited or removed in the future, and that your comment may appear alongside the original article on websites other than this one.

Error : Object reference not set to an instance of an object.

Recent Comments

Other News

Follow Asia Insurance Review